Therapy of recurrent disease after radical prostatectomy in 2007

World Journal of Urology

Volumn 25, Issue 2, 2007, Pages 161-167

  Schwarz, Rudolf ^a   Graefen, Markus ^b   Krüll, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Martini Clinic Prostate Cancer Center   (Germany)

Author keywords

Biochemical failure; Prostate cancer; PSA; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; HUMAN; MALE; PROSTATE TUMOR; PROSTATECTOMY; REVIEW; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 34047092769     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-007-0147-x     Document Type: Review

References (45)

1. Catalona WJ, Smith DS (1994) 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152:1837-1842
2. Kupelian PA, Katccher J, Levin HS, Klein EA (1997) Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Rad Oncol Biol Phys 37:1043-1052
3. Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF (1999) Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol 17:1155-1163
4. Anscher MS, Clough R, Dodge R (2000) Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: The first ten years. Int J Radiat Oncol Biol Phys 48:369-375
5. Cadeddu JA, Partin AW, De Weese TL, Walsh PC (1998) Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 159:173-177
6. Nudell DM, Grossfeld GD, Weinberg VK, Roach M III, Carroll PR (1999) Radiotherapy after radical prostatectomy: Treatment outcomes and failure patterns. Urology 54:1049-1057
7. Pisansky TM, Kozelsky TF, Myers RP, Hillmann DW, Blute ML, Buskirk SJ et al (2000) Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 163:845-850
8. Anscher MS, Prosnitz LR (1989) Radiotherapy vs. hormonal therapy for the management of locally recurrent prostate cancer following radical prostatectomy. Int J Rad Oncol Biol Phys 17:953-958
9. Wilder RB, Hsiang JY, Ji M, Earle JD, de Vere White R (2000) Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy. Am J Clin Oncol 23:176-180
10. Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, Mclean M et al (2001) Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 59:51-60
11. Zelefsky MJ, Aschkenasy E, Kelsen S (1997) Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 39:327-333
12. Egawa S, Ohori M, Iwamura M, Kuwao S, Baba S (1999) Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy. BJU Int 84:815-820
13. Kalapurakal JA, Huang CF, Neriamparampil MM, Small WJ, Pins MR, Mittal BB et al (2002) Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy. Int J Radiat Oncol Biol Phys 54:1047-1054
14. Chawla AK, Thakral HK, Zietman AL, Shipley WU (2002) Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. Urology 59:726-731
15. Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C et al (2002) (In)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 53:269-276
16. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE et al (2004) Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Rad Oncol Biol Phys 58:1530-1535
17. Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS et al (2004) Salvage radiotherapy for recurrent prostate cancer. JAMA 291:1325-1332
18. Macdonald OK, Schild SE, Vora SA et al (2003) Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol 170:1833-1837
19. Kaplan ID, Bagshaw MA (1992) Serum prostate-specific antigen after postprostatectomy radiotherapy. Urology 39:401-406
20. Montie JF (1994) Follow-up after radical prostatectomy or radiation therapy for prostate cancer. Urol Clin North Am 21:673-676
21. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh P (1993) Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20:713-725
22. Paulson DF (1994) Impact of radical prostatectomy in the management of clinically localized disease. J Urol 152:1826-1830
23. Johnstone PAS, Riffenburgh R (1997) Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients. Urol Oncol 3:108-112
24. Cher ML, Bianco Jr FJ, Lam JS, Davis LP, Grignon DJ, Sakr WA et al (1998) Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 160:1387-1391
25. Eulau SM, Tate DJ, Stamey TA, Bagshaw M, Hancock SL (1998) Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys 41:735-740
26. Peschel RE, Robnett TJ, Hesse D, King CR, Ennis RD, Schiff PB et al (2000) PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients. Int J Cancer 90: 29-36
27. Crane CH, Rich TA, Read PW, Sanfilippo NJ, Gillenwater JY, Kelly MD (1997) Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys 39:681-686
28. Do T, Parker RG, Do C, Tran L, Do L, Dolkar D (1998) Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Cancer J Sci Am 4:324-330
29. Mayer R, Pummer K, Quehenberger F, Mayer E, Fink L, Hackl A (2002) Postprostatectomy radiotherapy for high-risk prostate cancer. Urology 59:732-739
30. Morris MM, Dallow KC, Zietman AL, Park J, Althausen A, Heney NM et al (1997) Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 38:731-736
31. Rogers R, Grossfeld GD, Roach M III, Shinohara K, Presti JC, Carrol PR (1998) Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol 160:1748-1753
32. Vander Kooy MJ, Pisansky TM, Cha SS, Blute ML (1997) Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. Urology 9:65-70
33. Vicini FA, Ziaja EL, Kestin LL, Brabbins DS, Stromberg JS, Gonzalez JA et al (1999) Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology 54:111-117
34. Wiegel T, Bressel M, Arps H, Hübener KH (1992) Radiotherapy of local recurrence following radical prostatectomy. Strahlenther Onkol 168:333-336
35. Schwarz R, Kröll A, Tribius S, Alberti W (2005) Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy. Strahlenther Onkol 181:442-447
36. Medini E, Medini I, Reddy PK, Levitt SH (1996) Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up. Cancer 78:1254-1259
37. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW (1998) Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 42:501-506
38. De Merleer G, Vakaet L, de Gersem W, Villeirs G, De Neve W (2004) Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer. Strahlenther Onkol 180:136-143
39. Teh BS, Mai WY, Augspurger ME, Uhl BM, McGary J, Dong L et al (2001) Intensity modulated radiation therapy (IMRT)following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Rad Oncol Biol Phys 49:465-472
40. Bastasch MD, Teh BS, Mai WY, Carpenter LS, Lu HH, Chiu JK et al (2002) Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: Effect on erectile function. Int J Rad Oncol Biol Phys 54:101-106
41. Niehoff P, Kovacs G, Galalae R, Oldörp A, Kimmig B, Loch T et al (2001) Kombinierte Tele- und Brachytherapie beim Lokalrezidiv des Prostatakarzinoms nach radikaler Prostatektomie. Strahlenther Onkol 177(S1):S18
42. Losa A, Nava LD, Di Muzio N, Mangili P, Longobardi B, Rigatti P et al (2003) Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy. Urology 62:1068-1072
43. Haab F, Meulemans A, Boccon-Gibod L, Dauge MC, Delmas V, Hennequin C et al (1995) Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay. Urology 45:1022-1027
44. Garg MK, Tekyi-Mensah S, Bolton S, Velasco J, Pontes E, Wood DP et al (1998) Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. Urology 51:998-1002
45. Leventis AK, Shariat SF, Kattan MW, Butler B, Wheeler TM, Slawin KM (2001) Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 19:1030-1033